Comparing Nucynta ER vs Xtampza ER
Nucynta ER (tapentadol) | Xtampza ER (oxycodone) |
|
---|
Nucynta ER (tapentadol) | Xtampza ER (oxycodone) |
|
---|---|---|
Prescription only
Prescribed for Diabetic Peripheral Neuropathy, Pain. Nucynta ER may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Chronic Pain, Pain. Xtampza ER may also be used for purposes not listed in this medication guide. |
Related suggestions |
More about Nucynta ER (tapentadol) | More about Xtampza ER (oxycodone) | |
Ratings & Reviews | ||
Nucynta ER has an average rating of 7.2 out of 10 from a total of 81 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 19% reported a negative effect. |
Xtampza ER has an average rating of 3.9 out of 10 from a total of 169 ratings on Drugs.com. 24% of reviewers reported a positive effect, while 62% reported a negative effect. |
|
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
View all Nucynta ER side effects |
View all Xtampza ER side effects |
|
Drug Class | ||
Generic Availability | ||
Pricing and Coupons * Prices are without insurance | ||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
Dosage Forms | ||
|
N/A |
|
Brand Names | ||
Other tapentadol brands include: Nucynta | Other oxycodone brands include: Dazidox, Endocodone, ETH-Oxydose, Oxaydo, OxyContin, Oxydose, Oxyfast, Roxicodone, RoxyBond View more | |
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
4 hours |
5.6 hours |
|
CSA Schedule 1 View glossary of CSA terms | ||
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
|
Pregnancy Category | ||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
|
Drug Interactions | ||
A total of 422 drugs are known to interact with Nucynta ER:
|
A total of 624 drugs are known to interact with Xtampza ER:
|
|
Alcohol/Food/Lifestyle Interactions | ||
|
|
|
Disease Interactions | ||
|
||
First Approval Date | ||
August 25, 2011 |
April 26, 2016 |
|
WADA Class View classifications | ||
N/A |
||
More Information | ||
Patient Resources | ||
Professional Resources | ||
Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.